The 'Predict-First' Approach: How In Silico Strategies Can Enhance Efficiency In Monoclonal Antibody Bioprocess Development

By Arghya Barman, Ph.D., FUJIFILM Biotechnologies

To get a drug from discovery to a large-scale production, you need smart solutions in bioprocess development to make sure it's pure, high-quality, and effective. The main challenges are choosing the best cell clones, getting the highest possible yield, and ensuring the product is consistently good.

At FUJIFILM Biotechnologies, we use the kojoX™ philosophy to standardize our operations. This approach focuses on integrating precision and quality throughout every stage of development. We also use our own bioinformatics tools to speed up the process.

Our "Predict-First" approach helps us understand the "molecular personality" of each biomolecule. This means we can help our partners make sense of complex biological data and make smart, quick decisions that get their products to market faster.